Characterizing Heart Changes Related to Chemo-Radiotherapy
Tab Title Description
Describes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
- Scottsdale/Phoenix, Arizona: 17-008401
NCT ID: NCT04183218
Sponsor Protocol Number: MC1723
About this study
The purpose of this study is to determine the 12-month cardiac event rate after radiation or chemo-radiation for the treatment of lung or esophageal cancer.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
- Age ≥ 18 years.
- Planned standard of care curative thoracic RT or CRT with anticipated heart V40 > 20cc (At least 20cc of the heart should receive a dose of 40Gy or higher).
- Able to follow-up at all specified standard of care time-points.
- Patients can receive treatment as part of the standard of care or in a different study.
- Metastatic disease.
- Recurrent disease.
- Patient receiving radiation prescription doses lower than 40 Gy.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
|Mayo Clinic Location
Mayo Clinic principal investigator
Carlos Vargas, M.D.
Open for enrollment
Cancer Center Clinical Trials Referral Office
Publications are currently not available